Federal Judge Upholds FDA Approval of Pfizer's COVID-19 Treatment, Etoricoxabane, for High-Risk Patients

Summary

A federal judge has approved the FDA's decision to grant emergency use authorization for Pfizer's COVID-19 treatment, Etoricoxabane, for high-risk patients, following a review of the treatment's safety and efficacy data.